Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Emmanouil Lymperis"'
Autor:
Panagiotis Kanellopoulos, Emmanouil Lymperis, Aikaterini Kaloudi, Marion de Jong, Eric P. Krenning, Berthold A. Nock, Theodosia Maina
Publikováno v:
Molecules, Vol 25, Iss 15, p 3418 (2020)
Background: The frequent overexpression of gastrin-releasing peptide receptors (GRPRs) in human cancers provides the rationale for delivering clinically useful radionuclides to tumor sites using peptide carriers. Radiolabeled GRPR antagonists, beside
Externí odkaz:
https://doaj.org/article/ab4b2dceeec9415db7964c7407125a9d
Autor:
Emmanouil Lymperis, Aikaterini Kaloudi, Panagiotis Kanellopoulos, Marion de Jong, Eric P. Krenning, Berthold A. Nock, Theodosia Maina
Publikováno v:
Molecules, Vol 24, Iss 6, p 1015 (2019)
Background: The GRPR-antagonist 68Ga-SB3 visualized prostate cancer lesions in animal models and in patients. Switching radiometal from 68Ga to 111In impaired tumor targeting in mice, but coinjection of the neprilysin (NEP)-inhibitor phosphoramidon (
Externí odkaz:
https://doaj.org/article/0a3e438d255c49159c5032154fa1c5ec
Autor:
Aikaterini Kaloudi, Emmanouil Lymperis, Panagiotis Kanellopoulos, Beatrice Waser, Marion de Jong, Eric P. Krenning, Jean Claude Reubi, Berthold A. Nock, Theodosia Maina
Publikováno v:
Pharmaceuticals, Vol 12, Iss 1, p 42 (2019)
The overexpression of gastrin-releasing peptide receptors (GRPRs) in frequently occurring human tumors has provided the opportunity to use bombesin (BBN) analogs as radionuclide carriers to cancer sites for diagnostic and therapeutic purposes. We hav
Externí odkaz:
https://doaj.org/article/44b05b35e690421f94c8dafa8bd0a7a4
Autor:
Aikaterini Kaloudi, Emmanouil Lymperis, Athina Giarika, Simone Dalm, Francesca Orlandi, Donato Barbato, Mattia Tedesco, Theodosia Maina, Marion de Jong, Berthold A. Nock
Publikováno v:
Molecules, Vol 22, Iss 11, p 1950 (2017)
Background: The GRPR-antagonist-based radioligands [67/68Ga/111In/177Lu]NeoBOMB1 have shown excellent theragnostic profiles in preclinical prostate cancer models, while [68Ga]NeoBOMB1 effectively visualized prostate cancer lesions in patients. We wer
Externí odkaz:
https://doaj.org/article/2fd91a26029645ea860c5bc702710e95
Autor:
Theodosia Maina, Berthold A. Nock, Aikaterini Kaloudi, Panagiotis Kanellopoulos, Eric P. Krenning, Marion de Jong, Emmanouil Lymperis
Publikováno v:
Journal of Labelled Compounds & Radiopharmaceuticals, 62(10), 646-655. John Wiley & Sons Ltd.
Gastrin-releasing peptide receptors (GRPRs) are overexpressed in prostate cancer, representing attractive targets for diagnosis and therapy with bombesin (BBN)-like radioligands. GRPR-antagonists have lately attracted much attention owing to inherent
Autor:
Theodosia Maina, Panagiotis Kanellopoulos, Eric P. Krenning, Emmanouil Lymperis, Aikaterini Kaloudi, Berthold A. Nock, Marion de Jong
Publikováno v:
Molecules
Volume 25
Issue 15
Molecules, 25(15):3418. Multidisciplinary Digital Publishing Institute (MDPI)
Molecules, Vol 25, Iss 3418, p 3418 (2020)
Volume 25
Issue 15
Molecules, 25(15):3418. Multidisciplinary Digital Publishing Institute (MDPI)
Molecules, Vol 25, Iss 3418, p 3418 (2020)
Background: The frequent overexpression of gastrin-releasing peptide receptors (GRPRs) in human cancers provides the rationale for delivering clinically useful radionuclides to tumor sites using peptide carriers. Radiolabeled GRPR antagonists, beside
Autor:
Aikaterini, Kaloudi, Emmanouil, Lymperis, Panagiotis, Kanellopoulos, Beatrice, Waser, Marion, de Jong, Eric P, Krenning, Jean Claude, Reubi, Berthold A, Nock, Theodosia, Maina
Publikováno v:
Pharmaceuticals
The overexpression of gastrin-releasing peptide receptors (GRPRs) in frequently occurring human tumors has provided the opportunity to use bombesin (BBN) analogs as radionuclide carriers to cancer sites for diagnostic and therapeutic purposes. We hav
Autor:
Theodosia Maina, Eric P. Krenning, Panagiotis Kanellopoulos, Marion de Jong, Aikaterini Kaloudi, Berthold A. Nock, Emmanouil Lymperis
Publikováno v:
Molecules, 24(6):1015. Multidisciplinary Digital Publishing Institute (MDPI)
Molecules
Volume 24
Issue 6
Molecules, Vol 24, Iss 6, p 1015 (2019)
Molecules
Volume 24
Issue 6
Molecules, Vol 24, Iss 6, p 1015 (2019)
Background: The GRPR-antagonist 68Ga-SB3 visualized prostate cancer lesions in animal models and in patients. Switching radiometal from 68Ga to 111In impaired tumor targeting in mice, but coinjection of the neprilysin (NEP)-inhibitor phosphoramidon (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::207c285023a9646d477207ab5fc1951e
https://pure.eur.nl/en/publications/2090a6a4-ee81-4fb0-8320-bd242313df94
https://pure.eur.nl/en/publications/2090a6a4-ee81-4fb0-8320-bd242313df94
Autor:
Jean Claude Reubi, Eric P. Krenning, Theodosia Maina, Berthold A. Nock, Aikaterini Kaloudi, Beatrice Waser, Marion de Jong, Panagiotis Kanellopoulos, Emmanouil Lymperis
Publikováno v:
Pharmaceuticals, Vol 12, Iss 1, p 42 (2019)
Pharmaceuticals
Volume 12
Issue 1
Kaloudi, Aikaterini; Lymperis, Emmanouil; Kanellopoulos, Panagiotis; Waser, Beatrice; de Jong, Marion; Krenning, Eric P; Reubi, Jean Claude; Nock, Berthold A; Maina, Theodosia (2019). Localization of 99mTc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses. Pharmaceuticals, 12(1) MDPI 10.3390/ph12010042
Pharmaceuticals, 12(1):Unsp 42. Multidisciplinary Digital Publishing Institute (MDPI)
Pharmaceuticals
Volume 12
Issue 1
Kaloudi, Aikaterini; Lymperis, Emmanouil; Kanellopoulos, Panagiotis; Waser, Beatrice; de Jong, Marion; Krenning, Eric P; Reubi, Jean Claude; Nock, Berthold A; Maina, Theodosia (2019). Localization of 99mTc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses. Pharmaceuticals, 12(1) MDPI 10.3390/ph12010042
Pharmaceuticals, 12(1):Unsp 42. Multidisciplinary Digital Publishing Institute (MDPI)
The overexpression of gastrin-releasing peptide receptors (GRPRs) in frequently occurring human tumors has provided the opportunity to use bombesin (BBN) analogs as radionuclide carriers to cancer sites for diagnostic and therapeutic purposes. We hav
Autor:
Emmanouil, Lymperis, Aikaterini, Kaloudi, Panagiotis, Kanellopoulos, Eric P, Krenning, Marion, de Jong, Theodosia, Maina, Berthold A, Nock
Publikováno v:
Journal of labelled compoundsradiopharmaceuticalsREFERENCES. 62(10)
Gastrin-releasing peptide receptors (GRPRs) are overexpressed in prostate cancer, representing attractive targets for diagnosis and therapy with bombesin (BBN)-like radioligands. GRPR-antagonists have lately attracted much attention owing to inherent